BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Skin cancer AND MYC, c-Myc, 4609, ENSG00000136997
679 results:

  • 1. Interleukin 33 supports squamous cell carcinoma growth via a dual effect on tumour proliferation, migration and invasion, and T cell activation.
    Perri G; Vilas Boas VG; Nogueira MRS; Mello Júnior EJF; Coelho AL; Posadas EM; Hogaboam C; Cavassani KA; Campanelli AP
    Cancer Immunol Immunother; 2024 Apr; 73(6):110. PubMed ID: 38662248
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Mutational landscape of oral mucosal melanoma based on comprehensive cancer genomic profiling tests in a Japanese cohort.
    Ichimura N; Urata Y; Kobayashi T; Hibi H
    Oral Oncol; 2024 May; 152():106807. PubMed ID: 38615585
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. ATP Citrate Lyase is a General Tumour Biomarker and Contributes to the Development of Cutaneous Squamous Cell Carcinoma.
    Luo R; Huang Y; Bai R; Liu M; Sun L; Wang X; Zheng Y
    Acta Derm Venereol; 2024 Apr; 104():adv23805. PubMed ID: 38590175
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Arenobufagin inhibits lung metastasis of colorectal cancer by targeting c-myc/Nrf2 axis.
    Wang M; Hu S; Yang J; Yuan L; Han L; Liang F; Zhang F; Zhao H; Liu Y; Gao N
    Phytomedicine; 2024 May; 127():155391. PubMed ID: 38452690
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Review of the European Society for Photodynamic Therapy (Euro-PDT) Annual Congress 2022.
    Morton CA; Szeimies RM; Braathen LR
    Eur J Dermatol; 2023 Oct; 33(5):467-473. PubMed ID: 38297922
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. TIF1γ and SMAD4 regulation in colorectal cancer: impact on cell proliferation and liver metastasis.
    Wu Y; Yu B; Ai X; Zhang W; Chen W; Laurence A; Zhang M; Chen Q; Shao Y; Zhang B
    Biol Chem; 2024 Apr; 405(4):241-256. PubMed ID: 38270141
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Identification of peanut skin components for treating hepatocellular carcinoma via network pharmacology and in vitro experiments.
    Li S; Liu W; Wang TT; Chen TQ; Guo JC
    Chem Biol Drug Des; 2024 Jan; 103(1):e14428. PubMed ID: 38230768
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Hodgkin Lymphoma: A disease shaped by the tumor micro- and macroenvironment.
    Masel R; Roche ME; Martinez-Outschoorn U
    Best Pract Res Clin Haematol; 2023 Dec; 36(4):101514. PubMed ID: 38092473
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Delineating the early dissemination mechanisms of acral melanoma by integrating single-cell and spatial transcriptomic analyses.
    Wei C; Sun W; Shen K; Zhong J; Liu W; Gao Z; Xu Y; Wang L; Hu T; Ren M; Li Y; Zhu Y; Zheng S; Zhu M; Luo R; Yang Y; Hou Y; Qi F; Zhou Y; Chen Y; Gu J
    Nat Commun; 2023 Dec; 14(1):8119. PubMed ID: 38065972
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. EEF1A2 promotes HIF1A mediated breast cancer angiogenesis in normoxia and participates in a positive feedback loop with HIF1A in hypoxia.
    Patel SA; Hassan MK; Naik M; Mohapatra N; Balan P; Korrapati PS; Dixit M
    Br J Cancer; 2024 Feb; 130(2):184-200. PubMed ID: 38012382
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Melanocytic Neoplasm With KIT and APC Mutations: A New Subtype of Melanocytoma?
    Donati M; Grossmann P; Mansour B; Kazakov DV
    Am J Dermatopathol; 2024 Feb; 46(2):107-110. PubMed ID: 37982490
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Long noncoding RNA plasmacytoma variant translocation 1 is overexpressed in cutaneous squamous cell carcinoma and exon 2 is critical for its oncogenicity.
    Li C; Sun C; Mahapatra KD; Riihilä P; Knuutila J; Nissinen L; Lapins J; Kähäri VM; Homey B; Sonkoly E; Pivarcsi A
    Br J Dermatol; 2024 Feb; 190(3):415-426. PubMed ID: 37930852
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Anti-melanoma and antioxidant properties of the methanol extract from the leaves of
    Evariste Leonce AA; Devi P; Richard TS; Panda B; Devabattula G; Godugu C; Phelix Bruno T
    J Complement Integr Med; 2024 Mar; 21(1):88-100. PubMed ID: 37916849
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Tumor Profiles of Late Presentation Uveal Ring Melanoma With Novel Characteristics - A Case Series.
    Lim JZ; Crawford AZ; McGhee CNJ
    Invest Ophthalmol Vis Sci; 2023 Oct; 64(13):44. PubMed ID: 37889509
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. RIPK4 downregulation impairs Wnt3A-stimulated invasiveness via Wnt/β-catenin signaling in melanoma cells and tumor growth in vivo.
    Wronski N; Madej E; Grabacka M; Brożyna AA; Wolnicka-Glubisz A
    Cell Signal; 2024 Jan; 113():110938. PubMed ID: 37871667
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Identification of tumor-intrinsic drivers of immune exclusion in acral melanoma.
    Augustin RC; Newman S; Li A; Joy M; Lyons M; Pham MP; Lucas P; Smith K; Sander C; Isett B; Davar D; Najjar YG; Zarour HM; Kirkwood JM; Luke JJ; Bao R
    J Immunother Cancer; 2023 Oct; 11(10):. PubMed ID: 37857525
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. [Clinicopathological and prognostic features of subungual melanoma in situ].
    Hu J; Ren M; Cai X; Lyu JJ; Shen XX; Kong YY
    Zhonghua Bing Li Xue Za Zhi; 2023 Oct; 52(10):1006-1011. PubMed ID: 37805391
    [No Abstract]    [Full Text] [Related]  

  • 18. A novel method to assess copy number variations in melanocytic neoplasms: Droplet digital PCR for precise quantitation of myc and MYB genes.
    Ramos-Rodriguez AJ; McFadden JR; Momtahen S; LeBlanc RE; Yan S; Chaudhari AS; Cloutier JM; Stevanovic M; Barney R; Syku M; Lozano-Franco M; Hughes E; Sriharan A
    J Cutan Pathol; 2024 Feb; 51(2):146-154. PubMed ID: 37795541
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. The Effect of Cell-Free DNA from Blood Serum of Mice with Metastatic Melanoma on Enhancement of Oncogenic Properties of Melanoma Cells.
    Filatova AA; Alekseeva LA; Savin IA; Sen'kova AV; Zenkova MA; Mironova NL
    Biochemistry (Mosc); 2023 Jul; 88(7):995-1007. PubMed ID: 37751869
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Tumor-infiltrating lymphocyte transfusion in a patient with treatment refractory triple negative breast cancer.
    Jacover A; Zarbiv Y; Tal KH; Klein S; Breuer S; Durst R; Avni B; Grisariu S; Stepensky P; Lotem M; Maimon O; Yablonski-Peretz T
    Cancer Rep (Hoboken); 2023 Dec; 6(12):e1894. PubMed ID: 37750497
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 34.